Vascular Endothelial Growth Factor (VEGF) in sera of oral and oropharyngeal squamous cell carcinoma patients

Anticancer Research

Volumn 30, Issue 5, 2010, Pages 1765-1766

  Friedrich, Reinhard E ^a   Klapdor, Rainer ^b   Hagel, Christian ^a   Bartel Friedrich, Sylva ^c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Zentrum für Tumormarker in Diagnostik und Therapie ZeTDT   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Oral cancer; Oropharyngeal cancer; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; CANCER PATIENT; CANCER STAGING; CONFERENCE PAPER; FEMALE; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; ORAL SQUAMOUS CELL CARCINOMA; OROPHARYNGEAL SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; OROPHARYNGEAL NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77954579141     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (9)

1. Riedel F, Götte K, Schwalb J, Wirtz H, Bergler W and Hörmann K: Serum levels of vascular endothelial growth factor in patients with head and neck cancer. Eur Arch Otorhinolaryngol 257: 332-336, 2000.
2. Shang ZJ, Li JR and Li ZB: Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma. Int J Oral Maxillofac Surg 31: 495-498, 2002.
3. Li J, Dai CH, Chen P, Wu JN, Bao QL, Qiu H and Li XQ: Survival and prognostic factors in small cell lung cancer. Med Oncol 27: 73-81, 2010.
4. Li C, Shintani S, Terakado N, Klosek SK, Ishikawa T, Nakashiro K and Hamakawa H: Microvessel density and expression of vascular endothelial growth factor, basic fibroblast growth factor, and platelet-derived endothelial growth factor in oral squamous cell carcinomas. Int J Oral Maxillofac Surg 34: 559-565, 2005. (Pubitemid 40790355)
5. Uehara M, Sano K, Ikeda H, Sekine J, Irie A, Yokota T, Tobita T, Ohba S and Inokuchi T: Expression of vascular endothelial growth factor and prognosis of oral squamous cell carcinoma. Oral Oncol 40: 321-325, 2004. (Pubitemid 38121570)
6. Schimming R, Gellrich NC and Eyrich G: Markers in patients with squamous cell carcinoma of the oral cavity. Expression and long-term follow-up of VEGF, FLT-1 and Tie2 in serum. HNO 52: 235-241, 2004 (in German).
7. Johnstone S and Logan RM: The role of vascular endothelial growth factor (VEGF) in oral dysplasia and oral squamous cell carcinoma. Oral Oncol 42: 337-342, 2006.
8. Jablonska E, Puzewska W, Grabowska Z, Jablonski J and Talarek L: VEGF, IL-18 and NO production by neutrophils and their serum levels in patients with oral cavity cancer. Cytokine 30: 93-99, 2005.
9. Shang ZJ, Li JR and Li ZB: Upregulation of serum and tissue vascular endothelial growth factor correlates with angiogenesis and prognosis of oral squamous cell carcinoma. J Oral Maxillofac Surg 65: 17-21, 2007. (Pubitemid 44914030)